-
New results published in
@ScienceAdvances by#CIBSS members@MAJAFL Maja Banks-Köhn and Wolfgang Schamel@UniFreiburg together with Teresa Carlomagno from@UniHannover https://www.cibss.uni-freiburg.de/news/cibss-news/schamel-sci-adv-paper-2020/ …#SHP2#PD1#Immuneescape#CheckpointInhibitors pic.twitter.com/I3idRM2SBs
-
@MassGeneralNews &@harvardmed researchers use tumor#microenvironment data to calculate efficacy of#immunotherapy and predict#tumor response to#CheckpointInhibitors. CIRCULOGENE: One Tube, One Week, Complete Results. http://circulogene.com https://medicalxpress.com/news/2020-02-math-cancer-immunotherapy.html … -
Today is
#WorldCancerDay
! Explore our new #Cancer Immunology Virtual Issue featuring the latest research on#immunotherapy,#checkpointinhibitors, cancer#vaccination & the role of#Tregs@CEIjournal All free to access
https://buff.ly/38ZITpU pic.twitter.com/T6wKyp64rU
-
How to make
#checkpointinhibitors work for more patients? “One culprit behind a poor response to immunotherapy may be the immune system’s own first responders: neutrophils," writes@NIHDirector referencing@JCI_insight study led by our Dr. McGarry Houghtonhttps://bit.ly/2tcOLwX -
A systematic review of the methods used by RCTs to report health-related quality of life in cancer patients treated with immune
#CheckpointInhibitors finds there is a lack of questionnaires validated for cancer patients treated with#immunotherapy:http://bit.ly/2OejoJJ@PLOSONE -
Arthroscopy findings in arthritis induced by pembrolizumab: note synovial hypertrophy and hypervascularity
#arthritis#checkpointinhibitors#arthroscopypic.twitter.com/CS7tM9NS7z -
We are excited to see our review out, which includes a transplant section about all reported work on immune
#checkpointinhibitors' use in kidney#transplantation. Overall incidence of#rejection is ~50% with#anti-PD1 and about 35% with#anti-CTLA4. https://kidney360.asnjournals.org/content/early/2020/01/10/KID.0000852019 … https://twitter.com/ASNKidney360/status/1217114522839810048 …pic.twitter.com/YUrns6ZLTW
-
After analyzing tumor samples from 28 patients with non-small cell
#lungcancer, researchers linked a common immune cell with the failure of#CheckpointInhibitors. The culprit: neutrophils, the most abundant type of white blood cell.#lcsmhttps://bit.ly/2S92H4Z -
What adverse events are there from the use of immune
#checkpointinhibitors in patients with#IBD? A global group - including our own@DJPinato@ImperialSandC and@NickPowellLab@IHepatology - provide the answer, in this new paper in@JCO_ASCO@ASCO_pubs:https://ascopubs.org/doi/full/10.1200/JCO.19.01674?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed … -
#TBT: Now a staff clinician at@NCItreatment,@geosullivanc, MD, PhD was a#NIH_Heme_Onc_Fellow in 2012. The novel#cancer therapies she is developing using#pharmacokinetic &#pharmacodynamic tools include a#phase1 study of recombinant#interleukin15 with#checkpointinhibitors. pic.twitter.com/ZXfhe8Zqw4
-
Potential mechanisms of immune-related adverse events caused by immune
#CheckpointInhibitors. http://go.nature.com/2mtTDqB pic.twitter.com/iRVoW5a8Ln
-
EULAR Recommendations for immune-related adverse events of
#checkpointinhibitors treatment for cancer OP0165: all that rheumatologists need to know!#EULAR2019 >LA -
#CheckpointInhibitors work by releasing a natural brake on your immune system so that immune cells called T cells recognize and attack tumors.#ImmunoOnc#Immunotherapy#ASCO19pic.twitter.com/56qiWnoAit -
I can't leave
#pancchat without giving tribute to Dr. James Allison@CancerCureDoc (and his wife Dr. Pam Sharma--my@nyphospital residency friend) for winning the@NobelPrize for his work in the discovery of#checkpointinhibitors#immunotherapy#gamechanger#cancerbreakthroughpic.twitter.com/yeMOgUbnO4
-
Dr.Theodorescu
@CedarsSinai makes a strong case for functional genomic approaches to identify effective combinations with#immunotherapy#checkpointInhibitors, winning target DDR2#BladderCancer#AACRBC19pic.twitter.com/34SU46mY8Y
-
Enhancing antitumor response by combining immune
#checkpointinhibitors with chemotherapy in solid tumors http://bit.ly/2Yy2VDK#AACR19 -
Honored to have
@DanaFarber Dr. Stephen Hodi@NCIResearchCtr@theNCI grand rounds today discussing#immunotherapy with#Checkpointinhibitors therapy#CCRLecturepic.twitter.com/skXetLjJWi – mjesto: NIH Building 10 - Warren H. Magnuson Clinical Center
-
Experimental pathway shows real potential in treating
#pancreaticcancer with#checkpointinhibitors. New research from PICI's Jim Allison, PhD, and Padmanee Sharma, MD, PhD@MDAndersonNews. Story via@JohnCendpts@endpts#pancsm#immunotherapyhttps://bit.ly/2stbAs2 -
#EditorsChoice: Our editors pick some of their favourite#Reviews from 2018 Rheumatic immune-related adverse events from cancer immunotherapy#checkpointinhibitors#cancer#rheumatology#adverseeffects https://go.nature.com/2LN4VQT pic.twitter.com/6PPi9rwOgi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.